Overview

Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
This is an exploratory clinical trial designed to examine the efficacy, safety and tolerability of fospropofol (AQUAVAN) Injection compared to propofol (DISOPRIVAN) Injectable Emulsion when used to preoperatively sedate, induce, and maintain general anesthesia and to postoperatively sedate patients undergoing elective coronary artery surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
PPD
Treatments:
Anesthetics
Fospropofol
Propofol